Search
for
Sort by
Research 871–900 of 1000+
- Patterned Hair Loss
- Alopecia in a Linear Pattern
- Influência da Disbiose na Patologia do Couro Cabeludo
- Hair Transplantation
- Çocuklarda görülen saç ve saçlı deri hastalıklarının değerlendirilmesi
- Hair Transplantation
- Diffuse hair loss in women: causes and therapeutic approach
- Introduction
- New Drugs for Alopecias
- 522 Gut microbiota is required for the development of alopecia areata
- Evaluation of Serum Iron, Ferritin, Zinc and Folic Acid Levels in Female Patients with Diffuse Hair Loss
- Hair Transplant
- Hair Loss Myths.
- Congenital adrenal hyperplasia with polycystic ovarian disease: A rare cause of hirsutism
- Hormonal Treatment for Skin Androgen-Related Disorders
- Fifty-six years of plastic surgery
- Topical agents for hair growth promotion: what is out there?
- Faculty Opinions recommendation of Hair regrowth following a Wnt- and follistatin containing treatment: safety and efficacy in a first-in-man phase 1 clinical trial.
- A woman with headaches and blurred vision
- Therapie der androgenetischen Alopezie der Frau mit Minoxidil-Lösung
- [It is difficult to predict the effect of minoxidil liniment on hair loss in men].
- The type of androgenetic alopecia and quality of life (QoL) in male patients
- The comparison of demographics and comorbidities of female pattern hair loss according to the clinical subtype and stage
- IMPROVEMENT OF ALOPECIA AND DECREASES IN HAIR CORTISOL AND DIHYDROTESTOSTERONE CONCENTRATIONS AFTER THE TOPICAL USE OF PLANT EXTRACTS IN MEN WITH ANDROGENETIC ALOPECIA
- A NOVEL NANOGEL FORMULATION OF FINASTERIDE FOR TOPICAL TREATMENT OF ANDROGENETIC ALOPECIA: DESIGN, CHARACTERIZATION AND IN VITRO EVALUATION
- Androgenetic Alopecia (AGA)
- [What is the value of low-energie lasers in the treatment of androgenetic alopecia ?]
- Тіе Modern treatment of androgenetic alopecia
- [Female androgenetic alopecia, a survey of causes and therapeutic options].
- Faculty Opinions recommendation of Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trial.